Adherence will be calculated as the proportion of the number of sessions attended out of the number prescribed per protocol (32 sessions)
| Group | Value | 95% CI |
|---|---|---|
| All Participants | 0.95 | 0.81 – 1.00 |
Last reviewed · How we verify
Engaging Medically Complex Veterans in Tele-Rehabilitation Using a Biobehavioral Approach
NA trial testing Motivational Interviewing Techniques in Multimorbidity in 50 participants. Completed in 8 September 2023.
| Lead sponsor | VA Office of Research and Development |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | crossover |
| Masking | single |
| Primary purpose | treatment |
| Enrollment | 50 |
| Start date | 22 October 2021 |
| Primary completion | 7 August 2023 |
| Estimated completion | 8 September 2023 |
| Sites | 1 location across United States |
VA Office of Research and Development — full company profile →
60 and older, any sex, with Multimorbidity or Physical Deconditioning. Patients with the condition only — healthy volunteers not accepted.
Per-arm endpoint measurements with 95% confidence intervals where reported. Source: trial results section.
Adherence will be calculated as the proportion of the number of sessions attended out of the number prescribed per protocol (32 sessions)
| Group | Value | 95% CI |
|---|---|---|
| All Participants | 0.95 | 0.81 – 1.00 |
Physical activity will be measured via accelerometry and will include average 7-day step count
| Group | Value | 95% CI |
|---|---|---|
| All Participants | -95 | -514 – 915 |
Feasibility will be measured through a validated survey: Feasibility of Intervention Measure consists of 4 items rated on a 5-point Likert scale (1) completely disagree to (5) completely agree. The average of the 4 items are reported. Higher scores indicate greater feasibility of the program.
| Group | Value | 95% CI |
|---|---|---|
| All Participants | 5.0 | 4.8 – 5.0 |
Acceptability will be measured through a validated survey: Acceptability of Intervention Measure consists of 4 items rated on a 5-point Likert scale (1) completely disagree to (5) completely agree. The average of the 4 items are reported. Higher scores indicate greater acceptability of the program."
| Group | Value | 95% CI |
|---|---|---|
| All Participants | 5.0 | 4.7 – 5.0 |
Recruitment will be tracked as part of feasibility and to inform a future trial. Recruitment will be reported as a proportion of those enrolled out of the total number screened via phone screen.
| Group | Value | 95% CI |
|---|---|---|
| Recruitment | 50 |
Participation satisfaction with care provided via telerehabilitation will be assessed via the VA's approved survey: V-signals. It consists of 11 items rated on a 5-point Likert scale from (1) strongly disagree to (5) strongly agree). The average of the 11 items are reported. Higher scores indicate better satisfaction.
| Group | Value | 95% CI |
|---|---|---|
| All Participants | 4.9 | 4.6 – 5.0 |
The Safety Event Count is the cumulative number of study related (possibly, probably, or definitely) adverse events and severe adverse events counted from baseline to program end. Events will be categorized by type
| Group | Value | 95% CI |
|---|---|---|
| Multicomponent Telehealth Intervention (Group1) | 2 | |
| Education (Group2) | 1 |
| Group | Value | 95% CI |
|---|---|---|
| Multicomponent Telehealth Intervention (Group1) | 3 | |
| Education (Group2) | 1 |
| Group | Value | 95% CI |
|---|---|---|
| Multicomponent Telehealth Intervention (Group1) | 1 | |
| Education (Group2) | 0 |
| Group | Value | 95% CI |
|---|---|---|
| Multicomponent Telehealth Intervention (Group1) | 1 | |
| Education (Group2) | 3 |
| Group | Value | 95% CI |
|---|---|---|
| Multicomponent Telehealth Intervention (Group1) | 13 | |
| Education (Group2) | 19 |
| Group | Value | 95% CI |
|---|---|---|
| Multicomponent Telehealth Intervention (Group1) | 7 | |
| Education (Group2) | 10 |
| Group | Value | 95% CI |
|---|---|---|
| Multicomponent Telehealth Intervention (Group1) | 4 | |
| Education (Group2) | 2 |
| Group | Value | 95% CI |
|---|---|---|
| Multicomponent Telehealth Intervention (Group1) | 4 | |
| Education (Group2) | 10 |
Four-item questionnaire used to determine an individual's stage of change (pre-contemplation, contemplation, preparation, action, or maintenance)
| Group | Value | 95% CI |
|---|---|---|
| Multicomponent Telehealth Intervention (Group1) Baseline | 0 | |
| Multicomponent Telehealth Intervention (Group 1) 12 Weeks | 0 | |
| Education (Group2) Baseline | 1 | |
| Education (Group 2) 12 Weeks | 1 | |
| Multicomponent Telehealth Intervention (Group1) Baseline | 8 | |
| Multicomponent Telehealth Intervention (Group 1) 12 Weeks | 3 | |
| Education (Group2) Baseline | 12 | |
| Education (Group 2) 12 Weeks | 11 | |
| Multicomponent Telehealth Intervention (Group1) Baseline | 12 | |
| Multicomponent Telehealth Intervention (Group 1) 12 Weeks | 3 | |
| Education (Group2) Baseline | 6 | |
| Education (Group 2) 12 Weeks | 6 | |
| Multicomponent Telehealth Intervention (Group1) Baseline | 1 | |
| Multicomponent Telehealth Intervention (Group 1) 12 Weeks | 8 | |
| Education (Group2) Baseline | 2 | |
| Education (Group 2) 12 Weeks | 2 |
Nine item questionnaire used to measure an individual's self-efficacy for exercising under different conditions. Each item is rated on a scale of 0 (not confident) to 10 (confident). The average of the 9 items is calculated; higher scores indicate better self-efficacy. The change from baseline to 12 weeks is calculated as 12 weeks minus baseline; thus, positive change scores indicate improvement in self-efficacy.
| Group | Value | 95% CI |
|---|---|---|
| Multicomponent Telehealth Intervention (Group1) | 0.0 | -2.8 – 1.0 |
| Education (Group2) | 0.0 | -1.8 – 1.4 |
The test uses a standard height chair and requires the participant to stand up and sit down as many times as possible in 30 seconds. More completions indicate better physical function.
| Group | Value | 95% CI |
|---|---|---|
| Multicomponent Telehealth Intervention (Group1) | 1.0 | -1.0 – 4.0 |
| Education (Group2) | 1.0 | 0.0 – 2.0 |
This is a functional performance test for upper body strength and is performed on each arm (one arm at a time). It requires the participant to perform as many arm curls (biceps curls) as possible in 30 seconds. Males use an 8lb weight and females use a 5lb weight. Scores are continuous, and higher scores indicate greater arm strength (better outcome)
| Group | Value | 95% CI |
|---|---|---|
| Multicomponent Telehealth Intervention (Group1) | 3.0 | 0.0 – 5.0 |
| Education (Group2) | 0.5 | -1.5 – 4.0 |
| Group | Value | 95% CI |
|---|---|---|
| Multicomponent Telehealth Intervention (Group1) | 3.0 | 0.0 – 5.5 |
| Education (Group2) | 1 | -0.5 – 3.5 |
This is a functional performance test for aerobic endurance. It requires participants to march in place for 2 minutes (alternating legs), and the score is the number of repetitions completed on the right leg. Scores are continuous, and higher scores indicate better aerobic endurance.
| Group | Value | 95% CI |
|---|---|---|
| Multicomponent Telehealth Intervention (Group1) | 15.0 | 7.0 – 31.0 |
| Education (Group2) | 0.0 | -5.0 – 15.0 |
Time frame: 24 weeks. Reporting threshold: 5%. Adverse-event reports describe events observed during the trial — not all are caused by the drug.
| Reaction | System | Multicomponent Telehealth … | Education (Group 2) During… | Multicomponent Telehealth … | Education (Group 2) Not Du… |
|---|---|---|---|---|---|
| Fall | General disorders | — | — | — | — |
| Cardiac | Cardiac disorders | — | — | — | — |
| Musculoskeletal | Musculoskeletal and connective tissue disorders | — | — | — | — |
| Respiratory Infection | Respiratory, thoracic and mediastinal disorders | — | — | — | — |
Data from ClinicalTrials.gov NCT04942613 adverse events section.
The aims of this study are to determine the feasibility and acceptability of a multicomponent telerehabilitation program for medically complex older Veterans and to preliminarily assess participant outcomes (physical activity, physical function, quality of life, loneliness) to the program.
1 peer-reviewed publication reference this trial (live from Europe PMC):
Verify or expand the search:
Trials testing the same drug.
Currently open trials in the same condition.
Trials by the same sponsor.
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04942613.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing